https://pharmoniq.com/news/fda-warning-letter-american-pharma-manufacturing-gmp-violations PharmoniQ en 2026-10-03T14:10:48.994Z FDA Issues Warning Letter Over Serious Manufacturing Violations FDA, CGMP violations, warning letter, pharmaceutical manufacturing, regulatory compliance https://pharmoniq.com/news/fda-approves-first-once-weekly-insulin-type-2-diabetes PharmoniQ en 2026-10-03T08:47:02.690Z FDA Approves First Once-Weekly Insulin for Type 2 Diabetes FDA approval, insulin therapy, Type 2 Diabetes, medication adherence, once-weekly dosing https://pharmoniq.com/news/polypharmacy-surge-older-americans-drug-interaction-risks PharmoniQ en 2026-10-02T14:10:49.259Z Polypharmacy Surge Among Older Americans Reveals Drug Interaction Risks polypharmacy, drug interactions, elderly health, medication safety, prescription drugs